Wracked by deficiencies

he finalisation of rates was very low in the tender enquiries issued for rate contracts by MSO.

Wracked by deficiencies
Reportedly, Novartis also plans to share the long-term results from the trials in 2023. (File)

The Central Government Health Scheme (CGHS) suffers from many ailments, the Comptroller and Auditor General (CAG) of India has pointed out. The CGHS drug formulary hasn’t been updated to include new drugs prescribed by doctors, and thus the procurement of these under the scheme didnot happen between 2016 and 2022. Wellness Centres therefore had to purchase them from local chemists at higher rates. Of the 2,030 drugs listed in formulary, the Medical Store Organisation (MSO) finalised rate contracts for just 220-641 during 2016-17 to 2020-21.

Also read: A sporting nation: The Commonwealth Games success and a quiet revolution

The finalisation of rates was very low in the tender enquiries issued for rate contracts by MSO.

Get live Share Market updates and latest India News and business news on Financial Express. Download Financial Express App for latest business news.

Photos